TP53 and cancer: Invalidation of TMS1 in cultured cells induced a partial protection against TRAIL-induced p53-mediated apoptosis, however, contribution of TMS1 methylation to cancer progression is not clear as no correlation could be found between methylation and pathological changes in several cancers including cholangiocarcinoma [88,106].